Microbial limit detector Celsis Advance II™

for the pharmaceutical industrybioluminescencebenchtop

Future-proof your lab and prioritize patient safety and product quality with Celsis Advance II™. This instrument provides high throughput ATP-bioluminescence rapid microbiology detection that combines an easy-to-use workflow, minimizes changes to current test methods, and provides data integrity benefits through objective, automated analysis and reporting. Easy and Secure Rapid Microbial Detection The Celsis Advance II system delivers results in just 24-36 hours for microbial limits (USP ) quality control testing and 6 days for sterility testing (USP ), allowing you to rapidly confirm the quality of your products and quickly release them to market. The ability of this rapid microbial detection system to confidently confirm the absence of contamination allows your in-house quality system to: Shorten production cycle times Decrease working capital requirements as well as safety stock Reduce inventory requirements and warehouse space costs Receive earlier notification in the event of a contamination Respond to contamination and conduct investigations faster Celsis Advance II System Features Runs up to 120 assays per hour with the option of combining multiple batches or protocols into a single run Developed exclusively for large scale pharmaceutical and home and personal care manufacturing Offline incubation maximizes system throughput Compact, bench-top instrument The Celsis® assay rapidly confirms the presence or absence of microbial contamination using an amplified ATP-based bioluminescence reaction. Our method preserves your originally validated sample preparation methods, such as bioburden filtration or direct inoculation.